Sonoma Pharmaceuticals (SNOA) Non Operating Investment Income (2010 - 2011)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Non Operating Investment Income of $121000.0 in Q3 2011, up 26.04% quarter-over-quarter from $96000.0 in Q2 2011, and down 27.11% on a YoY basis from $166000.0 in Q3 2010.
Sonoma Pharmaceuticals (SNOA) Non Operating Investment Income (2010 - 2011) Analysis & Trends
Sonoma Pharmaceuticals' Non Operating Investment Income history runs 2 years deep, the most recent figure standing at $121000.0 for Q3 2011.
- In Q3 2011, Non Operating Investment Income fell 27.11% year-over-year to $121000.0; the TTM figure through Sep 2011 stood at $471000.0 (changed N/A YoY), while the FY2015 annual figure was -$4.6 million, changed N/A from the prior year.
- Non Operating Investment Income was $121000.0 for Q3 2011 at Sonoma Pharmaceuticals, up from $96000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $166000.0 in Q3 2010 to a low of $88000.0 in Q2 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Sonoma Pharmaceuticals | 1.87 Mn | -693,829.94 | 1.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 121,000.00 |
| Sep 30, 2011 | 121,000.00 |
| Jun 30, 2011 | 96,000.00 |
| Jun 30, 2011 | 96,000.00 |
| Sep 30, 2010 | 166,000.00 |
| Sep 30, 2010 | 166,000.00 |
| Jun 30, 2010 | 88,000.00 |
| Jun 30, 2010 | 88,000.00 |